Lilian Pfeiffer Lcsw P.a. | |
600 N Hiatus Rd Suite 201 Pembroke Pines FL 33026-5207 | |
(954) 801-5312 | |
(954) 212-0477 |
Full Name | Lilian Pfeiffer Lcsw P.a. |
---|---|
Speciality | Clinic/Center |
Location | 600 N Hiatus Rd, Pembroke Pines, Florida |
Authorized Official Name and Position | Lilian Pfeiffer (PRESIDENT) |
Authorized Official Contact | 9548015312 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Lilian Pfeiffer Lcsw P.a. 1950 Nw 107th Ave Pembroke Pines FL 33026-2318 Ph: (954) 801-5312 | Lilian Pfeiffer Lcsw P.a. 600 N Hiatus Rd Suite 201 Pembroke Pines FL 33026-5207 Ph: (954) 801-5312 |
NPI Number | 1639423890 |
---|---|
Provider Enumeration Date | 11/08/2012 |
Last Update Date | 11/08/2012 |
Medicare PECOS PAC ID | 8022254010 |
---|---|
Medicare Enrollment ID | O20130417000506 |
News Archive
Overweight and obese women with breast cancer may receive reduced doses of chemotherapy drugs, which may put them at greater risk of cancer recurrence, according to a study in the June 13 issue of Archives of Internal Medicine.
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Sepsis kills more people than breast, colorectal, pancreatic, and prostate cancers combined. Outside of coronary care units, it is the leading cause of mortality in intensive care units. Every year 18 million people worldwide develop this potentially fatal disease. Thanks to a generous grant of $138,238.65 from the Jesse and Julie Rasch Foundation, Lawson Health Research Institute's Dr. Michael Sharpe is exploring a new sepsis therapy using Vitamin C.
Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].
Fasting before getting your blood drawn for cholesterol tests is common practice, but new research from Michigan State University shows it is a contributing factor of low blood sugar, or hypoglycemia, in patients who take diabetes medications.
› Verified 3 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1639423890 | NPI | - | NPPES |
E0496A | Other | FL | MEDICARE PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | SW 4823 (Florida) | Primary |
Provider Name | Lilian Pfeiffer |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1477697399 PECOS PAC ID: 8628028651 Enrollment ID: I20050131000734 |
News Archive
Overweight and obese women with breast cancer may receive reduced doses of chemotherapy drugs, which may put them at greater risk of cancer recurrence, according to a study in the June 13 issue of Archives of Internal Medicine.
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Sepsis kills more people than breast, colorectal, pancreatic, and prostate cancers combined. Outside of coronary care units, it is the leading cause of mortality in intensive care units. Every year 18 million people worldwide develop this potentially fatal disease. Thanks to a generous grant of $138,238.65 from the Jesse and Julie Rasch Foundation, Lawson Health Research Institute's Dr. Michael Sharpe is exploring a new sepsis therapy using Vitamin C.
Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].
Fasting before getting your blood drawn for cholesterol tests is common practice, but new research from Michigan State University shows it is a contributing factor of low blood sugar, or hypoglycemia, in patients who take diabetes medications.
› Verified 3 days ago
News Archive
Overweight and obese women with breast cancer may receive reduced doses of chemotherapy drugs, which may put them at greater risk of cancer recurrence, according to a study in the June 13 issue of Archives of Internal Medicine.
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Sepsis kills more people than breast, colorectal, pancreatic, and prostate cancers combined. Outside of coronary care units, it is the leading cause of mortality in intensive care units. Every year 18 million people worldwide develop this potentially fatal disease. Thanks to a generous grant of $138,238.65 from the Jesse and Julie Rasch Foundation, Lawson Health Research Institute's Dr. Michael Sharpe is exploring a new sepsis therapy using Vitamin C.
Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].
Fasting before getting your blood drawn for cholesterol tests is common practice, but new research from Michigan State University shows it is a contributing factor of low blood sugar, or hypoglycemia, in patients who take diabetes medications.
› Verified 3 days ago
Efrain Mendez, Md Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 N Palm Ave, Suite 110a, Pembroke Pines, FL 33026 Phone: 954-399-8422 Fax: 954-399-8001 | |
Hope S Star Group Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7879 Pines Blvd Ste 101, Pembroke Pines, FL 33024 Phone: 786-531-8431 | |
Ilyssa Hershey Psyd Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 15757 Pines Blvd, Pmb 311, Pembroke Pines, FL 33027 Phone: 954-849-2012 Fax: 954-499-5913 | |
Rcs Exclusive Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 823 Nw 208th Ter, Pembroke Pines, FL 33029 Phone: 954-559-0011 | |
Community Behavioral Management,inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3 Sw 129th Ave Ste 203, Pembroke Pines, FL 33027 Phone: 954-589-2539 | |
Serenity Aba Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12542 Pines Blvd, Pembroke Pines, FL 33027 Phone: 954-391-9478 | |
Associates In Counseling And Psychiatry Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2225 N University Dr, Pembroke Pines, FL 33024 Phone: 954-962-6200 |